Clinical Scorecard: No-Fee CE: Myopia Beyond 2025
At a Glance
| Category | Detail |
|---|---|
| Condition | Myopia Management |
| Key Mechanisms | Parental myopia, reduced time outdoors, low hyperopic reserve, axial elongation. |
| Target Population | Children at risk for myopia and those already myopic. |
| Care Setting | Optometry and eyecare practices. |
Key Highlights
- FDA approval of a spectacle lens for myopia control in late 2025.
- Low hyperopic reserve is the greatest predictive factor for myopic progression.
- Increased time spent outdoors is associated with reduced risk of myopia onset.
- A 1-year delay in myopia onset can significantly lower final myopia levels.
- Emerging research indicates early changes in choroidal thickness may predict treatment efficacy.
Guideline-Based Recommendations
Diagnosis
- Assess parental myopia and hyperopic reserve.
- Monitor axial elongation in children.
Management
- Implement comprehensive myopia management programs.
- Provide lifestyle recommendations to enhance retinal signaling.
Monitoring & Follow-up
- Regularly evaluate retinal image quality and axial length.
Risks
- Children with low hyperopic reserve are at increased risk for developing myopia.
Patient & Prescribing Data
Children, particularly those with parental myopia and low hyperopic reserve.
Use evidence-based optical and/or pharmaceutical treatments to optimize retinal growth regulation.
Clinical Best Practices
- Encourage increased outdoor time for children.
- Utilize soft multifocal contact lenses for myopia management.
Related Resources & Content
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.